| Fund ID | 805-4132529247 |
| Fund type | Venture Capital Fund |
| 3(c)(1) exclusion | No |
| 3(c)(7) exclusion | Yes |
| Master fund | No |
| Feeder fund | No |
| Fund of funds | No |
| Relies on exemption from registration | Yes |
| Annual audit | Yes |
| Prepared per GAAP | Yes |
| Sub-advised | No |
| % of assets independently valued | 0% |
| Owned by the adviser or related persons | 2% |
| Owned by funds of funds | 23% |
| Owned by non-U.S. persons | 44% |
| Fund | Type | Gross assets |
|---|---|---|
| Decheng Capital Global Life Sciences Fund IV, L.P. | Venture Capital | $661.6M |
| Decheng Capital Global Life Sciences Fund V, L.P. | Venture Capital | $317M |
| Decheng Capital China Life Sciences Usd Fund II, L.P. | Venture Capital | $312.8M |
Decheng Capital China Life Sciences Usd Fund III, L.P. reports $503.7 million in gross assets, among the top 14% of private funds by size.
The stated minimum investment is $5 million.
Decheng Capital China Life Sciences Usd Fund III, L.P. is managed by Decheng Capital LLC.
No. Private funds are not required to publicly disclose performance. Form ADV reports assets, structure, and service providers.